RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $113,000 | -86.3% | 20,520 | -55.5% | 0.00% | -76.9% |
Q3 2021 | $824,000 | +943.0% | 46,076 | +345.5% | 0.01% | +550.0% |
Q4 2020 | $79,000 | -66.9% | 10,343 | -78.3% | 0.00% | -80.0% |
Q3 2020 | $239,000 | +132.0% | 47,772 | +178.2% | 0.01% | +100.0% |
Q2 2020 | $103,000 | – | 17,173 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 2,618,351 | $11,652,000 | 19.67% |
Flagship Pioneering Inc. | 38,296,526 | $170,419,000 | 7.99% |
HARBOURVEST PARTNERS LLC | 986,878 | $4,392,000 | 2.12% |
Abbot Financial Management, Inc. | 563,500 | $2,508,000 | 2.04% |
Artal Group S.A. | 3,883,791 | $17,283,000 | 0.73% |
ARK Investment Management | 318,121 | $1,416,000 | 0.04% |
Walleye Capital LLC | 34,000 | $151,000 | 0.03% |
Tekla Capital Management LLC | 155,982 | $694,000 | 0.03% |
Baillie Gifford | 4,256,900 | $18,943,000 | 0.02% |
FEDERATED HERMES, INC. | 600,000 | $2,670,000 | 0.01% |